Skip to main content
Etropal AD logo

Etropal AD — Investor Relations & Filings

Ticker · ETR ISIN · BG1100001038 LEI · 747800F04CMOK74FIJ68 BSOBGN Manufacturing
Open in API
Filings indexed 84 across all filing types
Latest filing 2025-12-01 Interim / Quarterly Rep…
Country BG Bulgaria
Listing BSOBGN ETR

About Etropal AD

https://www.etropal.eu/

Etropal AD is a manufacturer of disposable medical devices, primarily focused on providing life-sustaining care for patients with end-stage renal disease. The company's core activities include the research, development, and production of a comprehensive range of hemodialysis consumables, such as capillary dialyzers. In addition to its focus on dialysis solutions, the company is also active in the field of orthopedics and traumatology. This secondary business line involves the manufacturing of endoprostheses, implants, specialized bioceramic materials, and surgical instruments. With over thirty years of experience, Etropal AD offers a broad spectrum of products that meet high standards of safety and quality.

Recent filings

Filing Released Lang Actions
672553-2_Konsol. 2025 po MSS _ETROPAL_Q3.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a 'Consolidated Financial Report' (Консолидиран финансов отчет) covering the period ending September 30, 2025. It contains comprehensive financial statements, including the Statement of Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity, and Statement of Cash Flows. Since it covers a period shorter than a full fiscal year (nine months) and includes substantive financial data, it is classified as an Interim/Quarterly Report. 9M 2025
2025-12-01 Bulgarian
672559-Etropal_Q3_2025_Internal_information.pdf
Regulatory Filings Classification · 95% confidence The document is a short notification (725 characters) from 'Etropal AD' regarding the disclosure of inside information under Article 7 of EU Regulation No 596/2014. It directs the reader to an external financial media link (x3news.com) to access the actual information. Since it is a brief announcement regarding the publication of information rather than the detailed report itself, it falls under the category of a regulatory announcement.
2025-12-01 Bulgarian
Declaration_100о_Q3'2025_ETR_cons.pdf
Regulatory Filings Classification · 95% confidence The document is a formal declaration signed by the executive director and the accountant of Etropal AD. It serves as an officer certification confirming that the interim consolidated financial report and the management report for Q3 2025 are accurate and fair. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report, should be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements. 9M 2025
2025-12-01 Bulgarian
Declaration_100о_Q2'2025_ETR_con.pdf
Regulatory Filings Classification · 95% confidence The document is a formal declaration (certification) signed by the executive director and the accountant of Etropal AD. It confirms the accuracy of the interim consolidated financial report and the interim management report for the second quarter of 2025. According to the 'Certification Rule', documents that are primarily officer certifications or attestations, even if they reference a specific report type, should be classified as Regulatory Filings (RNS) rather than the report itself, as this document does not contain the actual financial statements or substantive data. H1 2025
2025-08-28 Bulgarian
661980-Etropal_Q2_2025_Prilojenie_4.pdf
Legal Proceedings Report Classification · 100% confidence The document is a regulatory disclosure form (Appendix 4) required by Bulgarian Ordinance No. 2 regarding the disclosure of information for public companies. It covers various corporate events such as changes in control, insolvency proceedings, material transactions, and legal proceedings. Since it is a general regulatory disclosure document that does not fit into specific categories like financial reports or shareholder meetings, it is classified as a Regulatory Filing (RNS).
2025-08-28 Bulgarian
661979-Etropal_Q2_2025_Additional_information.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Additional Information to the Interim Financial Report' for the period ending 30.06.2025. It provides detailed management commentary, shareholder data, and disclosures required by Bulgarian regulatory ordinance regarding interim financial reporting. Since it contains substantive management analysis and disclosures related to the interim financial period, it is classified as an Interim/Quarterly Report (IR). H1 2025
2025-08-28 Bulgarian

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.